Medical Oncologist with interest in Breast Cancer Treatment
Localização: Centro Champalimaud
Entidade Empregadora: Fundação Champalimaud
Regime: Tempo Inteiro
Posição: Medico/a
Início da Candidatura: 30 Ago. 2024
About the Position
We are seeking a dedicated and experienced Medical Oncologist with interest in breast cancer treatment to join our dynamic and multidisciplinary oncology team. This is a full-time position, primarily focused on outpatient clinical care, with responsibilities that include on-call duties and collaboration with inpatient services. We offer a competitive salary.
Key Responsibilities
* Provide high-quality care to breast cancer patients in the outpatient clinical setting;
* Participate in on-call rotations, approximately 12 hours twice monthly, to support chemotherapy services;
* Offer consultancy for the inpatient oncology floor as needed;
* Collaborate with a multidisciplinary team to assess patient needs accurately and develop personalised treatment plans;
* Participate actively in weekly clinical and educational meetings;
* Engage in clinical trials, including the review of clinical research protocols, patient recruitment, and treatment within both industry-sponsored and academic trials;
* Potential for protected research time for candidates who meet specific selection criteria.
Desired Qualifications & Experience
* MD with specialised training in Medical Oncology and eligibility to practice in the EU/Portugal (equivalent to “Assistente Hospitalar” or “Consultant”).
* Proven experience in the medical treatment of breast cancer patients.
* Experience and active involvement in clinical trials.
* Proficiency in spoken and written Portuguese and English.
* Strong motivation to work in a fast-paced, clinical environment.
* Excellent interpersonal and communication skills.
Application Process
Interested candidates are invited to submit their CV along with a cover letter detailing their relevant experience and motivation for applying to sofia.braganca@fundacaochampalimaud.pt
Deadline for Applications: 31 December 2024.
#J-18808-Ljbffr